Methodological and preanalytical evaluation of an HMGB1 immunoassay

Anticancer Research

Volumn 32, Issue 5, 2012, Pages 2059-2062

  Lehner, Julia ^a   Wittwer, Christin ^a   Fersching, Debora ^a   Siegele, Barbara ^a   Holdenrieder, Stefan ^a,b   Stoetzer, Oliver J ^c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c Hematology/Oncology Outpatient Center   (Germany)

Author keywords

ELISA testing; HMGB1; Immunoassay; Preanalytics; Serum; Stability

Indexed keywords

EDETIC ACID; HIGH MOBILITY GROUP B1 PROTEIN;

ARTICLE; CENTRIFUGATION; DILUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FREEZING; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; METHODOLOGY; NORMAL HUMAN; PRIORITY JOURNAL; STORAGE TEMPERATURE;

BLOOD PRESERVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HMGB1 PROTEIN; HUMANS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 84861489009     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Tang D, Kang R, Zeh HJ 3rd and Lotze MT: High mobility group box 1 (HMGB1) and Cancer. Biochim Biophy Acta 1799: 131-140, 2010.
2. Bianchi ME: HMGB1 loves company. J Leukoc Biol 86: 573-576. 2009.
3. Lotze MT and Tracey KJ: High mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nat Rev 5: 331-342, 2005. (Pubitemid 40516158)
4. Campana L, Bosurgi L and Rovere-Querini P: HMGB1: a twoheaded signal regulating tumor progression an immunity. Curr Opin Immunol 20: 518-523, 2008.
5. Sims GP, Rowe DC, Rietdijk ST, Herbst R and Coyle AJ: HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 28: 367-388, 2010.
6. Bell CW, Jiang W, Reich CF 3rd and Pisetsky DS: The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol 291: C1318-1325, 2006. (Pubitemid 44878603)
7. Urbonaviciute V, Fürnrohr BG, Meister S, Munoz L, Heyder P, De Marchis F, Bianchi ME, Kirschning C, Wagner H, Manfredi AA, Kalden JR, Schett G, Rovere-Querini P, Herrmann M and Voll RE: Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med 205: 3007-3018, 2008.
8. Scaffidi P, Misteli T and Bianchi ME: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191-195, 2002. (Pubitemid 34773774)
9. Wang H, Yang H and Tracey KJ: Extracellular role of HMGB1 in inflammation and sepsis. Intern Med 255: 320-331, 2004. (Pubitemid 38324549)
10. Ellermann JE, Brown CK, de Vera M, Zeh HJ 3rd, Billiar T, Rubartelli A and Lotze MT: Masquerader: high mobility group box-1 and cancer. Clin Cancer Res 13: 2836-2848, 2007. (Pubitemid 46850704)
11. Shen X, Hong L, Sun H, Shi M and Song Y: The expression of high-mobility group protein box 1 correlates with the progression of non-small cell lung cancer. Oncol Rep 22: 535-539, 2009.
12. Urbonaviciute V and Voll RE: HMGB1 represents a potential marker of disease activity and novel therapeutic target in SLE. J Intern Med 270: 309-318, 2011.
13. Goldstein RS, Bruchfeld A, Yang L, Qureshi AR, Gallowitsch- Puerta M, Patel NB, Huston BJ, Chavan S, Rosas-Ballina M, Gregersen PK, Czura CJ, Sloan RP, Sama AE and Tracey KJ: Cholinergic anti-inflammatory pathway activity and high mobility group box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Mol Med 13: 210-215, 2007. (Pubitemid 46944965)
14. Holdenrieder S, Mueller S and Stieber P: Stability of nucleosomal DNA fragments in serum. Clin Chem 51: 1026-1029, 2005. (Pubitemid 40740887)